Literature DB >> 16014564

A thrombomodulin mutation that impairs activated protein C generation results in uncontrolled lung inflammation during murine tuberculosis.

Sebastiaan Weijer1, Catharina W Wieland, Sandrine Florquin, Tom van der Poll.   

Abstract

Thrombomodulin (TM) plays an essential role in the generation of activated protein C (APC), a mediator with both anticoagulant and anti-inflammatory properties, and is preferentially expressed in lungs. To investigate the role of TM in the coagulant and inflammatory response in the lung during tuberculosis, mice with a mutation in the TM gene (Thbd), which results in a minimal capacity for APC generation (TMpro/pro mice), were intranasally infected with live virulent Mycobacterium tuberculosis. Whereas pulmonary tuberculosis was not associated with activation of coagulation in either wild-type or TMpro/pro mice, 5 weeks after infection TMpro/pro mice displayed an uncontrolled inflammatory response in their lungs, as reflected by higher lung weights, a diminished ability to form well-shaped granulomas, elevated levels of proinflammatory cytokines, and concurrently reduced concentrations of anti-inflammatory cytokines. During a 36-week follow-up after infection with a lower dose of M tuberculosis, 35% of TMpro/pro mice died from week 28 onward versus none of the wild-type mice, and the surviving TMpro/pro mice displayed increased lung inflammation accompanied by higher mycobacterial loads in liver and spleen. These data suggest that a TM mutation that impairs APC generation results in uncontrolled lung inflammation during tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014564     DOI: 10.1182/blood-2004-12-4623

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain.

Authors:  Netanel A Horowitz; Elizabeth A Blevins; Whitney M Miller; Ashley R Perry; Kathryn E Talmage; Eric S Mullins; Matthew J Flick; Karla C S Queiroz; Kun Shi; C Arnold Spek; Edward M Conway; Brett P Monia; Hartmut Weiler; Jay L Degen; Joseph S Palumbo
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

2.  Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.

Authors:  Payam Nahid; Erin Bliven-Sizemore; Leah G Jarlsberg; Mary A De Groote; John L Johnson; Grace Muzanyi; Melissa Engle; Marc Weiner; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  Tuberculosis (Edinb)       Date:  2014-02-07       Impact factor: 3.131

3.  Osteopontin is not crucial to protective immunity during murine tuberculosis.

Authors:  Gerritje J W van der Windt; Catharina W Wieland; Willem J Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

4.  CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis.

Authors:  Catharina W Wieland; Gerritje J W van der Windt; W Joost Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2008-04-03       Impact factor: 7.397

5.  A thrombomodulin mutation that impairs active protein C generation is detrimental in severe pneumonia-derived gram-negative sepsis (melioidosis).

Authors:  Liesbeth M Kager; W Joost Wiersinga; Joris J T H Roelofs; Onno J de Boer; Hartmut Weiler; Cornelis van 't Veer; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

6.  Role of tissue factor in Mycobacterium tuberculosis-induced inflammation and disease pathogenesis.

Authors:  Hema Kothari; Shiva Keshava; Rit Vatsyayan; Nigel Mackman; L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

7.  Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.

Authors:  Mary A De Groote; Payam Nahid; Leah Jarlsberg; John L Johnson; Marc Weiner; Grace Muzanyi; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

8.  Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth.

Authors:  Helen A Fletcher; Alana Keyser; Mark Bowmaker; Peter C Sayles; Gilla Kaplan; Greg Hussey; Adrian V S Hill; Willem A Hanekom
Journal:  BMC Med Genomics       Date:  2009-02-24       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.